[The treatment of myeloproliferative syndromes].
A review is presented of the clinical, physiopathological and therapeutic aspects of four varieties of chronic myeloproliferative syndrome: polycythemia vera, idiopathic thrombocythemia, chronic myelocytic leukemia and idiopathic myeloid metaplasia. Routine and experimental therapeutic approaches are discussed.
D000368:Aged; D001815:Bloodletting; D002066:Busulfan / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy; D008297:Male; D009196:Myeloproliferative Disorders / Q000628:therapy*; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000628:therapy; D055728:Primary Myelofibrosis / Q000628:therapy; D012075:Remission, Spontaneous; D013922:Thrombocytosis / Q000628:therapy
D010761:Phosphorus Radioisotopes; D002699:Chlorambucil; D002066:Busulfan
Le traitement des syndromes myéloprolifératifs